Safety and Efficacy Study of Antioxidants for the Treatment of the Fragile X Syndrome

NCT01329770 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
30
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Yolanda de Diego Otero